High Hopes Dash As Breakthrough Heart Drug Fails Key Clinical Trial
Medical researchers are grappling with a surprising setback after an experimental drug designed to prevent heart attacks and strokes failed to deliver promised results. The medication, known as pelacarsen, was specifically engineered to target lipoprotein(a),